Toxic Dolls | Rytter Brock | Activity https://toxicdolls.com/members/sortcable51/activity/ Activity feed for Rytter Brock. Thu, 14 May 2026 22:11:49 +0000 https://buddypress.org/?v= en-US 30 hourly 2 d7a8aa76da9ec32e272b48d9473b2027 Rytter Brock posted an update: Ixazomib, the first oral proteasome inhibitor (PI), has been […] https://toxicdolls.com/activity-2/p/13625/ Sat, 28 Jun 2025 10:56:20 +0000 Ixazomib, the first oral proteasome inhibitor (PI), has been approved for the treatment of relapsed refractory multiple myeloma (RRMM) in combination with lenalidomide and dexamethasone, based on the TOURMALINE-MM1 phase 3 trial, which demonstrated the efficacy and safety of this all-oral triplet, compared with lenalidomide-dexamethasone. However,…[Read more]

]]> 0 941bfedea5efda05d021c8b7a9ebfa5e Rytter Brock posted an update: To evaluate the clinical presentation of choanal atresia (CA) […] https://toxicdolls.com/activity-2/p/10152/ Tue, 24 Jun 2025 11:35:59 +0000 To evaluate the clinical presentation of choanal atresia (CA) in tertiary centers across Canada.

Multi-centre case series involving six tertiary care pediatric hospitals across Canada. Retrospective chart review of patients born between 1980 and 2010 diagnosed with CA at a participating center.

The health charts of 215 patients…[Read more]

]]> 0 885b7edbaa50dfdd5fc62ff968206687 Rytter Brock posted an update: This journal is © The Royal Society of Chemistry […] https://toxicdolls.com/activity-2/p/8313/ Mon, 23 Jun 2025 11:23:15 +0000 This journal is © The Royal Society of Chemistry 2019.Plasmonic nanoparticle (NP)-mediated photothermal therapy (PPTT) has been explored as a minimally invasive approach to cancer therapy and has progressed from concept to the early stage of clinical trials. Better understanding of the cellular and molecular response to PPTT is crucial for…[Read more]

]]> 0 361b1e6b18642baf0bd5f98ac8b7d620 Rytter Brock became a registered member https://toxicdolls.com/activity-2/p/8268/ Mon, 23 Jun 2025 10:46:07 +0000 0